Nasdaq Stocks

Akero Therapeutics, Inc. (AKRO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to disco

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Credit rating agency Moody’s Investors Service recently confirmed the Tenet Healthcare Corporation’s THC B2 Corporate Family Rating, B2-PD Probability of Default Rating and Caa1 senior unsecured ratings. The credit rating giant downgraded the company’s current senior secur

Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced detailed positive results from a late-stage study evaluating asthma drug, Dupixent.

Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 6th:

Moderna, Inc. MRNA shares have surged 78.1% so far this year against the industry’s decline of 8.6%, riding on the progress of its development of coronavirus vaccine.

Haemonetics Corporation HAE announced that it acquired enicor GmbH, a Germany-based privately held manufacturer of a new-generation whole blood coagulation testing system called ClotPro. Per the terms of the agreement, all the outstanding share capital of enicor are now part of

Investors in Frontline Ltd. FRO need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2020 $9.00 Call had some of the highest implied volatility of all equity options today.  

Chimera Investment Corporation CIM has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at CIM given that, according to its RSI reading of 28.47, it is

Fate Therapeutics, Inc. FATE was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $17.

Investors in Benefytt Technologies, Inc. BFYT need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2020 $18 Call had some of the highest implied volatility of all equity options today.

Investors in RH RH need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2020 $50.00 Put had some of the highest implied volatility of all equity options today.  

One Liberty Properties, Inc. OLP was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stoc